These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 9226205

  • 1. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment.
    Vitti P, Rago T, Chiovato L, Pallini S, Santini F, Fiore E, Rocchi R, Martino E, Pinchera A.
    Thyroid; 1997 Jun; 7(3):369-75. PubMed ID: 9226205
    [Abstract] [Full Text] [Related]

  • 2. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B, Hoermann R, Roggenbuck U, Hahn S, Mann K, Janssen OE, Basedow Study Group.
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [Abstract] [Full Text] [Related]

  • 3. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
    Carella C, Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Nersita R, Iorio S, Amato G, Braverman LE, Roti E.
    Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study.
    Cappelli C, Gandossi E, Castellano M, Pizzocaro C, Agosti B, Delbarba A, Pirola I, De Martino E, Rosei EA.
    Endocr J; 2007 Dec; 54(5):713-20. PubMed ID: 17675761
    [Abstract] [Full Text] [Related]

  • 5. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
    Choo YK, Yoo WS, Kim DW, Chung HK.
    Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
    [Abstract] [Full Text] [Related]

  • 6. Post-partum and non-post-partum relapsing Graves' hyperthyroidism display different response to anti-thyroid drugs.
    Rotondi M, Capelli V, Coperchini F, Pinto S, Croce L, Tonacchera M, Chiovato L.
    Eur J Endocrinol; 2018 Jun; 178(6):589-594. PubMed ID: 29559498
    [Abstract] [Full Text] [Related]

  • 7. Graves disease in children: thyroid-stimulating hormone receptor antibodies as remission markers.
    Gastaldi R, Poggi E, Mussa A, Weber G, Vigone MC, Salerno M, Delvecchio M, Peroni E, Pistorio A, Corrias A.
    J Pediatr; 2014 May; 164(5):1189-1194.e1. PubMed ID: 24518168
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene.
    Kinjo Y, Takasu N, Komiya I, Tomoyose T, Takara M, Kouki T, Shimajiri Y, Yabiku K, Yoshimura H.
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2593-6. PubMed ID: 12050220
    [Abstract] [Full Text] [Related]

  • 10. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A.
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [Abstract] [Full Text] [Related]

  • 11. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease.
    Schott M, Morgenthaler NG, Fritzen R, Feldkamp J, Willenberg HS, Scherbaum WA, Seissler J.
    Horm Metab Res; 2004 Feb; 36(2):92-6. PubMed ID: 15002058
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of the medical treatment of Graves' disease (GD)].
    Peixoto MC, Coeli CM, Vaisman M.
    Arq Bras Endocrinol Metabol; 2005 Jun; 49(3):410-9. PubMed ID: 16543996
    [Abstract] [Full Text] [Related]

  • 13. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M, Koizumi Y, Aizawa T, Yamada T, Takahashi Y, Watanabe T, Kamoi K.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [Abstract] [Full Text] [Related]

  • 14. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F, González-Ortiz M, Durón H, Sánchez C.
    Rev Invest Clin; 2002 Jan; 54(4):307-10. PubMed ID: 12415954
    [Abstract] [Full Text] [Related]

  • 15. A patient-specific treatment model for Graves' hyperthyroidism.
    Pandiyan B, Merrill SJ, Di Bari F, Antonelli A, Benvenga S.
    Theor Biol Med Model; 2018 Jan 09; 15(1):1. PubMed ID: 29310665
    [Abstract] [Full Text] [Related]

  • 16. [Long-term follow up after antithyroid drug treatment in Graves' disease].
    Wille T, Müller B, Noth D, Bürgi U, Diem P.
    Praxis (Bern 1994); 2006 Jul 19; 95(29-30):1121-7. PubMed ID: 16916174
    [Abstract] [Full Text] [Related]

  • 17. B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study.
    El Fassi D, Nielsen CH, Bonnema SJ, Hasselbalch HC, Hegedüs L.
    J Clin Endocrinol Metab; 2007 May 19; 92(5):1769-72. PubMed ID: 17284622
    [Abstract] [Full Text] [Related]

  • 18. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K, Amino N, Kubota S, Sasaki I, Nishihara E, Kudo T, Ito M, Fukata S, Miyauchi A.
    Clin Endocrinol (Oxf); 2010 Jun 19; 72(6):845-50. PubMed ID: 19912243
    [Abstract] [Full Text] [Related]

  • 19. Graves' disease: evolution and prognosis after eight months of treatment with methimazole.
    Gauna AT, Guillén CE, Sartorio GC, Soto RJ.
    Medicina (B Aires); 1992 Jun 19; 52(3):207-12. PubMed ID: 1364158
    [Abstract] [Full Text] [Related]

  • 20. Outcome of Graves' disease after antithyroid drug treatment in Taiwan.
    Wang PW, Liu RT, Tung SC, Chien WY, Lu YC, Chen CH, Kuo MC, Hsieh JR, Wang ST.
    J Formos Med Assoc; 1998 Sep 19; 97(9):619-25. PubMed ID: 9795530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.